Endo Launches First Generic Version of Noxafil® (posaconazole) Injection
DUBLIN, June 29, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18 mg/mL), the first generic version of Merck's Noxafil® in the U.S., followi...
Source: marketscreener.com
